Citation tools

Degn, Kristine B. et al "One Week’s Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and α- and β-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes." Diabetes 53.5 (2004): 1187-1194. Web. 08 Mar. 2021.

Citation Manager Formats